Table 2 Blood levels of PCDDs/PCDFs/Co-PCBs (in pg/g lipid and pg TEQ/g lipid) and total TEQ of participants (N = 490) in SEDOCCH 2011–2016

 2,3,7,8-TeCDD

378 (77.1)

<LOD

<LOD

<LOD

2. 0 (2.0–2.0)

 1,2,3,7,8-PeCDD

51 (10.4)

2.0 (2.0–2.0)

3.0 (3.0–3.0)

4.0 (4.0–4.0)

7.0 (6.0–8.0)

 1,2,3,4,7,8-HxCDD

442 (90.2)

<LOD

<LOD

<LOD

3.0 (2.0–3.0)

 1,2,3,6,7,8-HxCDD

15 (3.0)

5.0 (5.0–5.0)

8.0 (8.0–9.0)

12.2 (12.0–14.0)

23.0 (20.0–25.0)

 1,2,3,7,8,9-HxCDD

345 (70.4)

<LOD

<LOD

2.0 (2.0–2.0)

4.0 (4.0–5.0)

 1,2,3,4,6,7,8-HpCDD

3 (0.6)

5.5 (5.0–6.0)

7.0 (7.0–7.1)

10.0 (9.0–10.0)

17.0 (15.0–19.9)

 OCDD

0 (0.0)

67.0 (64.0–70.0)

96.0 (91.0–100.0)

130.0 (130.0–150.0)

284.5 (241.2–320.0)

 Total PCDDs (pg/g lipid)

–

82.0 (79.0–86.0)

120.0 (110.0–120.0)

160.0 (150.0–180.0)

320.0 (290.0–359.9)

 Total PCDDs (pg TEQ/g lipid)

–

2.5 (2.4–2.6)

3.8 (3.6–4.0)

5.9 (5.3–6.2)

11.2 (9.9–12.7)

 2,3,7,8-TeCDF

366 (74.6)

<LOD

<LOD

<LOD

2.0 (2.0–2.0)

 1,2,3,7,8-PeCDF

398 (81.2)

<LOD

<LOD

<LOD

2.0 (1.0–2.0)

 2,3,4,7,8-PeCDF

9 (1.8)

4.0 (4.0–4.0)

5.0 (5.0–5.0)

7.0 (7.0–7.5)

12.0 (11.0–13.9)

 1,2,3,4,7,8-HxCDF

325 (66.3)

<LOD

< LOD

2.0 (2.0–2.0)

4.0 (3.0–5.0)

 1,2,3,6,7,8-HxCDF

229 (46.7)

<LOD

2.0(<LOD–2.0)

3.0 (3.0–3.0)

5.0 (5.0–6.0)

 1,2,3,7,8,9-HxCDF

490 (100.0)

<LOD

<LOD

<LOD

<LOD

 2,3,4,6,7,8-HxCDF

460 (93.8)

<LOD

<LOD

<LOD

2.0 (<LOD–2.0)

 1,2,3,4,6,7,8-HpCDF

374 (76.3)

<LOD

<LOD

<LOD

4.0 (3.0–5.0)

 1,2,3,4,7,8,9-HpCDF

490 (100.0)

<LOD

<LOD

<LOD

<LOD

 OCDF

490 (100.0)

<LOD

<LOD

<LOD

<LOD

 Total PCDFs (pg/g lipid)

–

4.0 (4.0–4.0)

8.0 (7.0–9.0)

13.0 (12.0–14.0)

26.0 (23.1–30.0)

 Total PCDFs (pg TEQ/g lipid)

–

1.2 (1.2–1.2)

1.8 (1.7–1.9)

2.6 (2.4–2.8)

4.7 (4.2–5.3)

 Total (PCDDs+PCDFs) (pg/g lipid)

–

89.0 (85.0–96.0)

130.0 (120.0–131.9)

172.5 (160.0–190.0)

334.5 (300.0–379.9)

 Total (PCDDs+PCDFs) (pg TEQ/g lipid)

–

3.8 (3.6–4.0)

5.7 (5.3–6.0)

8.3 (7.7–8.9)

16.0 (14.0–18.0)

Co-PCBs (non-ortho PCBs and mono-ortho PCBs)

Non-ortho PCBs (pg/g lipid)

3,3′,4,4’-TeCB (#77)

489 (99.8)

< LOD

< LOD

< LOD

< LOD

3,4,4′,5-TeCB (#81)

490 (100.0)

< LOD

< LOD

< LOD

< LOD

3,3′,4,4′,5-PeCB (#126)

56 (11.4)

20.0 (10.0–20.0)

20.0 (20.0–30.0)

40.0 (40.0–50.0)

90.0 (80.0–100.0)

3,3′,4,4′,5,5’-HxCB (#169)

28 (5.7)

20.0 (20.0–20.0)

25.0 (20.0–30.0)

40.0 (30.0–40.0)

74.5 (70.0–90.0)

Total non-ortho PCBs (pg/g lipid)

–

30.0 (30.0–40.0)

50.0 (50.0–50.0)

80.0 (70.0–90.0)

164.5 (141.2–180.0)

Total non-ortho PCBs (pg TEQ/g lipid)

–

2.1 (1.6–2.6)

3.2 (2.9–3.6)

5.2 (4.8–5.9)

11.4 (10.2–12.7)

2,3,3′,4,4’-PeCB (#105)

0 (0.0)

600.0 (544.3–650.0)

940.0 (890.0–1000.0)

1600.0 (1400.0–1756.2)

3400.0 (2900.0–3899.2)

 2,3,4,4′,5-PeCB (#114)

0 (0.0)

180.0 (160.0–190.0)

290.0 (250.0–320.0)

480.0 (440.0–530.0)

1000.0 (881.2–1100.0)

 2,3′,4,4′,5-PeCB (#118)

0 (0.0)

3175.0 (2900.0–3500.0)

5200.0 (4800.0–5600.0)

8400.0 (7800.0–9400.0)

18,000.0 (16,000.0–20,000.0)

 2′,3,4,4′,5-PeCB (#123)

2 (0.4)

50.0 (40.0–50.0)

70.0 (70.0–80.0)

130.0 (120.0–140.0)

284.5 (231.2–349.9)

 2,3,3′,4,4′,5-HxCB (#156)

0 (0.0)

1300.0 (1200.0–1400.0)

2100.0 (1980.4–2300.0)

3300.0 (3000.0–3600.0)

7045.0 (5912.0–8398.4)

 2,3,3′,4,4′,5’-HxCB (#157)

0 (0.0)

350.0 (330.0–380.0)

570.0 (530.0–610.0)

880.0 (800.0–970.0)

1900.0 (1600.0–2200.0)

 2,3′,4,4′,5,5’-HxCB (#167)

0 (0.0)

530.0 (480.0–570.0)

850.0 (790.0–940.0)

1300.0 (1200.0–1500.0)

3045.0 (2612.5–3300.0)

 2,3,3′,4,4′,5,5’-HpCB (#189)

0 (0.0)

177.5 (160.0–190.0)

270.0 (250.0–290.0)

412.5 (390.0–450.0)

984.5 (833.7–1199.6)

 Total mono-ortho PCBs (pg/g lipid)

–

6800.0 (6200.0–7200.0)

10,500.0 (9600.0–11,000.0)

16,250.0 (15,000.0–18,000.0)

34,450.0 (31,000.0–38,996.2)

 Total mono-ortho PCBs (pg TEQ/g lipid)

–

0.2 (0.2–0.2)

0.3 (0.3–0.3)

0.5 (0.5–0.5)

1.0 (0.9–1.2)

 Total Co-PCBs (pg/g lipid)

–

6800.0 (6200.0–7200.0)

11,000.0 (9700.0–12,000.0)

17,000.0 (15,000.0–18,000.0)

34,450.0 (31,124.9–38,996.2)

 Total Co-PCBs (pg TEQ/g lipid)

–

2.4 (1.8–2.8)

3.6 (3.2–3.9)

5.7 (5.2–6.6)

12.0 (11.0–14.0)

Total (PCDDs + PCDFs + Co-PCBs) (pg/g lipid)

–

6915.0 (6267.1–7326.4)

11,057.0 (9848.7–11,857.8)

17,066.0 (15,202.8–18,191.6)

35,187.4 (31,280.6–39,107.0)

Total (PCDDs + PCDFs + Co-PCBs) (pg TEQ/g lipid)

–

6.1 (5.5–6.6)

9.4 (8.8–9.9)

14.0 (13.0–9.9)

27.5 (24.0–31.0)